alphaveABBOTINDIA₹25,230.00

Abbott India Ltd.

₹ CrorePeersPFIZER GLAXO IPCALAB AJANTPHARM ANTHEM MEDANTA GLENMARK BIOCON

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026
Returns
Return on Common Equity	32.48	33.41	32.51
Return on Assets	23.13	23.90	23.87
Return on Capital Employed	35.89	35.98	36.14
Margins
EBITDA Margin	24.84	26.44	27.31
Operating Margin	23.63	25.32	26.21
Incremental Operating Margin	—	42.99	37.18
Pretax Margin	27.66	29.44	30.01
Net Income Margin	20.54	22.07	22.40
FCF Margin	20.74	15.79	19.04
Additional
Effective Tax Rate	25.75	25.04	25.36
Dvd Payout Ratio	—	—	65.03
Sustainable Growth Rate	32.48	33.41	11.37
Incremental Operating Margin %	42.99	37.18	—

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.